Stomach mapping may predict G-POEM success in gastroparesis

NCT ID NCT06493032

Recruiting now Knowledge-focused Sponsor: Indiana University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a non-invasive device called Body Surface Gastric Mapping can predict which patients with gastroparesis will benefit from G-POEM surgery. Researchers will monitor 20 patients before and after the procedure using a sticky electrode patch on the stomach area. The goal is to see if the device's readings match surgical outcomes and help guide treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Gastric Alimetry System (Body Surface Gastric Mapping device)
What this could lead to: If successful, this could help doctors identify which gastroparesis patients are most likely to benefit from G-POEM surgery, avoiding unnecessary procedures.
What could go wrong: This is a very small, early study (20 people) that is only observing outcomes, not testing a treatment. The device may not reliably predict surgical success.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROPARESIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastroparesis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTROPARESIS

Contacts and locations

Locations

Indiana University Health University Hospital
RECRUITING

Indianapolis, Indiana, 46202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.